All
Outcomes
Market
Price
AI Fair
Value
Value
Edge
June 30
YesNo
March 31
YesNo
December 31
YesNo
AI Insights:
03.15 23:21 UpdatedFair Value Reasoning:
Based on the latest administrative status, the DEA ALJ hearing process has not commenced as of mid-March 2026, stalled by a pending interlocutory appeal and a shortage of administrative law judges. Even if the appeal were resolved today, the mandatory APA steps (Hearing, ALJ Report, DEA Review, Final Rule cooling-off) require a minimum of 6-9 months. Therefore, rescheduling by 'June 30' is procedurally impossible (Fair Value approaches 0). The 'December 31' window is also critically endangered, with industry experts now citing 'early-to-mid 2027' as the realistic baseline, making the current 37c pricing a significant overvaluation of administrative efficiency.
Sign up to view more information
Arbitrage|Low Risk
Arbitrage Plan:
Buy 'June 30 - No' (Current Cost ~80c)
Plan Description:
A massive mispricing exists. Due to the ALJ hearing not having started, it is physically impossible to complete the statutory rescheduling process within 3.5 months (by June 30). The current 'Yes' price of 20c (implying 20% probability) contrasts with a real-world probability of <1%. Buying 'No' at 80c is virtually risk-free, yielding a payoff of 100c by end of June, representing a ~25% absolute return and >85% annualized yield.Sign up to view more information
Arbitrage: 0¢
|Annualized yield: 85.7%
Hedging
CRON
CGC
ACB
TLRY
MSOS
Rescheduling marijuana (down from Schedule I) would have a massive fundamental impact on the US cannabis industry, most directly by removing Section 280E tax restrictions, significantly improving cash flows for cannabis companies. Therefore, this event is highly correlated with cannabis ETFs (like MSOS) and major cannabis stocks (Tilray, Canopy Growth, etc.). It is a classic policy-driven trade; unexpected outcomes (e.g., a sudden announcement or definitive failure) would cause extreme volatility in these assets.
Movers
March 14, 2026 - March 15, 2026, the 'June 30' option rebounded from 12c to 20c, driven by speculative buying ('dead cat bounce') that ignored the reality of administrative stagnation.
March 13, 2026 - March 14, 2026, 'June 30' crashed from 35.5c to 12c, and 'December 31' fell from 57.5c to 37c, as the market priced in confirmation of the 'Indefinite Delay' regarding the ALJ hearings, realizing that H1 2026 and potentially full-year 2026 targets are now procedurally unviable.
Divergence
Significant divergence. Market pricing (37% probability for Dec completion) is substantially higher than legal expert consensus. Experts widely believe that due to the interlocutory appeal and ALJ backlog, rescheduling is realistically pushed to 2027, while the market retains an irrational hope for political intervention in 2026.